Member Info for draft

Valeant/Sprout
Deal size: $1 billion
Date announced: August 19, 2015

It’s the smallest deal in our M&A mistake ranks, but Sprout Pharmaceuticals certainly made big headlines a few years back. The company won a controversial FDA approval in 2015 for its female libido drug Addyi, and one day later, Valeant swooped in with a deal.

The drugmaker picked up Sprout for $1 billion plus future milestones in what then-CEO Michael Pearson called the “perfect opportunity to establish a new portfolio of important medicines that uniquely impact women.” At the time, the company figured it could make the most of a first-of-its-kind treatment in what was expected to be a blockbuster field.

ovoca Bio doesnt have much competition out there at all with most female libido drugs failing and not doing well

Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/f6fa1f66-6a26-4ae0-b5a2-560c887b1998

$20bn
The amount Microsoft has pledged to spend on cyber security measures over five years, four times its current rate of investment
Following the meeting, the White House said the National Institute of Standards and Technology would work with companies to improve the integrity of the “software supply chain” and address weaknesses found within the patchwork of technologies and protocols that underpin many services.

Pichai said Alphabet’s Google unit would participate in that initiative and invest more than $10bn in cyber security during the next five years. The company pledged to train 100,000 Americans in related fields.

Arvind Krishna, IBM chief executive, said his company would train 150,000 workers in cyber security over the next three years, working closely with historically black colleges and universities.

Microsoft, which was the victim of a cyber attack in March, said it would spend $20bn on cyber security over five years, four times its current rate of investment. In addition, it would provide $150m in technical services to the national and local governments.

Amazon, which did not attach a monetary figure to its efforts, said it would share training materials it provided to its employees to guard against cyber attacks with the public.

he doesnt answer the phone nor reply to messages

https://en.wikipedia.org/wiki/Partner_Communications_Company

Used to be Orange

https://israelrescue.org/

Interesting extension to defib project. emergency bike ambulances

A major emergency service provider in Israel, United Hatzalah, has chosen our Helios Pro solution for the deployment of smart lifesaving technology. In partnership with Partner Telecommunication, Starcom is providing smart defibrillator cabinets that can be controlled and monitored by United Hatzalah operators and deployed in public areas for emergency response.

https://www.potatonewstoday.com/2021/08/26/cropx-and-pepsico-mexico-to-help-latin-americas-potato-farmers-to-improve-farm-management-practices/

CropX are seriously busy, bizarre how this doesnt give STAR big sales rise

I just dont see how cancord have got away with a 33p price forecast on this

"Water scarcity in Mexico is severe, and with an ever-increasing demand, combined with the fact that agriculture accounts for almost 78% of water use, certain cities in Mexico risk being void of water. "With PepsiCo using CropX's data-driven soil management platform in large scale we have the opportunity to make a huge impact and to significantly improve water-use inefficiency and soil health for potato production in Mexico." said Matan Rahav, Director of Business Development at CropX. "The collaboration with PepsiCo will help the Mexican potato farming industry become more efficient and sustainable. We're very excited to have partnered with one of the world's leading food corporations which has committed to help tackle some of the world's most pressing challenges." Producers working with PepsiCo Mexico can now get the benefits of CropX sensor technology and artificial intelligence software – from money savings by irrigation and fertilizer efficiency and higher yields by optimizing water usage, to the peace of mind that comes from maintaining the ideal environment and growing conditions for crops. Together, PepsiCo and CropX will empower Mexican potato producers to improve farm management practices. PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated more than $64 billion in net revenue in 2018, driven by a complementary food and beverage portfolio that includes Frito-Lay, Gatorade, Pepsi-Cola, Quaker and Tropicana. PepsiCo's product portfolio includes a wide range of enjoyable foods and beverages, including 22 brands that generate more than $1 billion each in estimated annual retail sales. Guiding PepsiCo is our vision to Be the Global Leader in Convenient Foods and Beverages by Winning with Purpose.

For more information, visit www.pepsico.com.

About PepsiCo Latin America

PepsiCo Latin America is a division that includes all of its beverage, food and snack businesses in Latin America, comprising 34 emerging and developing markets. Our beverage, food and snacks businesses in Latin America include snacks, beverages, cookies & crackers and nutrition categories, which generated US $7.4 billion dollars in net revenue in 2018. Our Beverages business in the region operates through 13 major bottlers.

still no one knows who he is

DHL suddenly sounds like a new trial to monitor the DHL fleet based on the wording used.

https://www.prnewswire.com/news-releases/pepsico-chooses-cropx-to-achieve-global-sustainability-goals-301362544.html

Courtesy of Col on Twitter

maybe they should have gone to CARD factory and looked inside a helium balloon

https://www.investorschronicle.co.uk/ideas/2021/08/25/a-potential-turnaround-play-in-healthcare/

A healthcare opportunity?
One stock that is on my radar and has been since 2017 is a company called OptiBiotix (OPTI). It’s one that I read the RNS announcements of and keep track of the story. Recently, the fundamentals appear to be strengthening. In the company’s final results in June, revenue grew 104 percent to £1.5 million. It’s still loss making, but in a recent trading update the company mentioned it was ahead in its first half and expects to meet full-year expectations.

Chart 1 shows the clear sideways trend that persisted in OptiBiotix between 2016 and the summer of 2018. I’ve marked three arrows: the first being support, the middle being the chart breakout marked with an arrow, and the top arrow marking the breakout from multi-year highs. However, this rally was short lived, although the stock did double from the lows within 12 months. Moving across to Chart 2, I’ve marked with arrows where the stock has tested and failed to break resistance. This means that if the stock can break 70p then it’s a hugely bullish indicator. If the price has failed to break this level several times and then goes through it, the price is clearly telling us that the trend may be changing. Many people claim that support and resistance is for novices, but some of my best trades have come from being patient, waiting for the fundamentals to start getting stronger, and watching for the technical breakout in alignment. For this reason, I’ve set an alert for OptiBiotix at 70p. I also note that the company has a large shareholding in SkinBioTherapeutics (SBTX), which was spun out of the company. As of 30 June 2021, this was worth £22,948,048 on the company’s balance sheet, with the market cap of the company being £46.6 million at a share price of 53p. This should mean that no severely discounted placing will be on the way, as the company can just sell some shares for cash. However, I caveat this with what ‘should mean’ does not always mean it does happen!

for ciitech when that medicinal cannabis company relists

Looks like no one has read the rns properly
Over 3 years
Still need final approval etc.

that doesnt help. who is it? any ideas? cant find anyone on google other than a plumber

who is the new Tr1 holder? (excuse the pun)

paying 300mill for this, at a stretch maybe 60-70mill if they really need and want it for their vaccines

DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has been selected as a partner for the University of Leeds following a £1.4M EPSRC investment they received to develop automated precision manufacturing approaches in collaboration with the University of Sheffield, AstraZeneca, Somaserve and Samsung.

DeepMatter will provide its DigitalGlassware® platform, a cloud-based platform that allow chemists to share data in real-time and develop digitally enabled scale-up of advanced nanoparticle products. Nanoparticles are an important component in ensuring safe and effective drug delivery of new-generation (mRNA) VACCINES and certain anti-cancer drugs. The technology to digitally enable the scale-up of advanced nanoparticle products will be a sustainable, cost-effective alternative to the current method of production, and brings innovation beyond a laboratory setting across several manufacturing environments.

DigitalGlassware® was selected due to its strong fit for early-stage chemical development. It comprises a cloud-based software platform, which allows scientists to easily bring together digitised synthesis protocols (recipes) and contextualises time-course sensor streams from a range of analytical instrumentation, importantly in real-time.